CONGENITAL HYPERINSULINISM
Clinical trials for CONGENITAL HYPERINSULINISM explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HYPERINSULINISM trials appear
Sign up with your email to follow new studies for CONGENITAL HYPERINSULINISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to control blood sugar in kids with rare condition
Disease control CompletedThis study is testing the long-term safety of dasiglucagon, a drug given as a continuous injection under the skin, in children with congenital hyperinsulinism (a condition causing dangerously low blood sugar). The trial includes 42 children who completed earlier studies. Research…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a smarter glucose monitor stop dangerous lows? small study tests predictive alerts
Symptom relief CompletedThis completed study tested whether a continuous glucose monitor with predictive alerts (Dexcom G7) can reduce low blood sugar better than a standard alert monitor (Dexcom ONE+) in 11 adults with glycogen storage disease or congenital hyperinsulinism. Participants wore each devic…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: NA • Sponsor: University Hospital Padova • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC